200 related articles for article (PubMed ID: 32614247)
1. Epidemiology of Treatment for Preschoolers on Kentucky Medicaid Diagnosed with Attention-Deficit/Hyperactivity Disorder.
Davis DW; Feygin Y; Creel L; Kong M; Jawad K; Sun J; Blum NJ; Lohr WD; Williams PG; Le J; Jones VF; Pasquenza N
J Child Adolesc Psychopharmacol; 2020 Sep; 30(7):448-455. PubMed ID: 32614247
[No Abstract] [Full Text] [Related]
2. Longitudinal Trends in the Diagnosis of Attention-Deficit/Hyperactivity Disorder and Stimulant Use in Preschool Children on Medicaid.
Davis DW; Feygin Y; Creel L; Williams PG; Lohr WD; Jones VF; Le J; Pasquenza N; Ghosal S; Jawad K; Yan X; Liu G; McKinley S
J Pediatr; 2019 Apr; 207():185-191.e1. PubMed ID: 30545564
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy patterns and predictors of ADHD in commercially insured and Medicaid populations.
Molife C; Bernauer MJ; Farr AM; Haynes VS; Kelsey D
Postgrad Med; 2012 Sep; 124(5):7-22. PubMed ID: 23095422
[TBL] [Abstract][Full Text] [Related]
4. α2-Adrenergic Agonists or Stimulants for Preschool-Age Children With Attention-Deficit/Hyperactivity Disorder.
Harstad E; Shults J; Barbaresi W; Bax A; Cacia J; Deavenport-Saman A; Friedman S; LaRosa A; Loe IM; Mittal S; Tulio S; Vanderbilt D; Blum NJ
JAMA; 2021 May; 325(20):2067-2075. PubMed ID: 33946100
[TBL] [Abstract][Full Text] [Related]
5. Common Use of Stimulants and Alpha-2 Agonists to Treat Preschool Attention-Deficit Hyperactivity Disorder: A DBPNet Study.
Blum NJ; Shults J; Harstad E; Wiley S; Augustyn M; Meinzen-Derr JK; Wolraich ML; Barbaresi WJ
J Dev Behav Pediatr; 2018 Sep; 39(7):531-537. PubMed ID: 29851669
[TBL] [Abstract][Full Text] [Related]
6. Disparities in ADHD Diagnosis and Treatment by Race/Ethnicity in Youth Receiving Kentucky Medicaid in 2017.
Davis DW; Jawad K; Feygin Y; Creel L; Kong M; Sun J; Lohr WD; Williams PG; Le J; Jones VF; Trace M; Pasquenza N
Ethn Dis; 2021; 31(1):67-76. PubMed ID: 33519157
[TBL] [Abstract][Full Text] [Related]
7. First-line Behavioral Health Treatment Prior to Stimulant or Alpha-2 Agonist Use for Preschoolers on Kentucky Medicaid in 2017.
Davis DW; Jawad K; Lohr WD; Trace M; Le J; Feygin Y; Jones VF
J Atten Disord; 2023 Feb; 27(4):437-446. PubMed ID: 36635886
[TBL] [Abstract][Full Text] [Related]
8. Young Children with Attention-Deficit/Hyperactivity Disorder and/or Disruptive Behavior Disorders Are More Frequently Prescribed Alpha Agonists Than Stimulants.
Mittal S; Boan AD; Kral MC; Lally MD; van Bakergem K; Macias MM; LaRosa A
J Child Adolesc Psychopharmacol; 2020 Mar; 30(2):81-86. PubMed ID: 31621385
[No Abstract] [Full Text] [Related]
9. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF
Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
[TBL] [Abstract][Full Text] [Related]
10. Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population.
Radigan M; Lannon P; Roohan P; Gesten F
J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):44-56. PubMed ID: 15741785
[TBL] [Abstract][Full Text] [Related]
11. ADHD medication use, adherence, persistence and cost among Texas Medicaid children.
Barner JC; Khoza S; Oladapo A
Curr Med Res Opin; 2011; 27 Suppl 2():13-22. PubMed ID: 21973228
[TBL] [Abstract][Full Text] [Related]
12. Attention-Deficit/Hyperactivity Disorder in 2- to 5-Year-Olds: A Primary Care Network Experience.
Bannett Y; Feldman HM; Gardner RM; Blaha O; Huffman LC
Acad Pediatr; 2021 Mar; 21(2):280-287. PubMed ID: 32360494
[TBL] [Abstract][Full Text] [Related]
13. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
[TBL] [Abstract][Full Text] [Related]
14. Association of Coexisting Conditions, Attention-Deficit/Hyperactivity Disorder Medication Choice, and Likelihood of Improvement in Preschool-Age Children: A Developmental Behavioral Pediatrics Research Network Study.
Deavenport-Saman A; Vanderbilt DL; Harstad E; Shults J; Barbaresi W; Bax A; Cacia J; Friedman S; LaRosa A; Loe I; Mittal S; Blum N
J Child Adolesc Psychopharmacol; 2022 Aug; 32(6):328-336. PubMed ID: 35787014
[No Abstract] [Full Text] [Related]
15. Medicaid Prior Authorization Policies for Medication Treatment of Attention-Deficit/Hyperactivity Disorder in Young Children, United States, 2015.
Hulkower RL; Kelley M; Cloud LK; Visser SN
Public Health Rep; 2017; 132(6):654-659. PubMed ID: 29072963
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of prescribed attention-deficit hyperactivity disorder medications and diagnosis among Canadian preschoolers and school-age children: 1994-2007.
Brault MC; Lacourse É
Can J Psychiatry; 2012 Feb; 57(2):93-101. PubMed ID: 22340149
[TBL] [Abstract][Full Text] [Related]
17. Receipt of Medication and Behavioral Therapy Among a National Sample of School-Age Children Diagnosed With Attention-Deficit/Hyperactivity Disorder.
Walls M; Allen CG; Cabral H; Kazis LE; Bair-Merritt M
Acad Pediatr; 2018 Apr; 18(3):256-265. PubMed ID: 29061327
[TBL] [Abstract][Full Text] [Related]
18. Polypharmacy in the Management of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Review and Update.
Baker M; Huefner JC; Bellonci C; Hilt R; Carlson GA
J Child Adolesc Psychopharmacol; 2021 Apr; 31(3):148-163. PubMed ID: 33600217
[No Abstract] [Full Text] [Related]
19. Vital Signs: National and State-Specific Patterns of Attention Deficit/Hyperactivity Disorder Treatment Among Insured Children Aged 2-5 Years - United States, 2008-2014.
Visser SN; Danielson ML; Wolraich ML; Fox MH; Grosse SD; Valle LA; Holbrook JR; Claussen AH; Peacock G
MMWR Morb Mortal Wkly Rep; 2016 May; 65(17):443-50. PubMed ID: 27149047
[TBL] [Abstract][Full Text] [Related]
20. Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder: 1995-99.
Robison LM; Sclar DA; Skaer TL; Galin RS
Int Clin Psychopharmacol; 2004 Jan; 19(1):17-22. PubMed ID: 15101565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
